Combined Targeting of mTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex.
about
Combined Targeting of mTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined Targeting of mTOR and ...... of Tuberous Sclerosis Complex.
@en
Combined Targeting of mTOR and ...... of Tuberous Sclerosis Complex.
@nl
type
label
Combined Targeting of mTOR and ...... of Tuberous Sclerosis Complex.
@en
Combined Targeting of mTOR and ...... of Tuberous Sclerosis Complex.
@nl
prefLabel
Combined Targeting of mTOR and ...... of Tuberous Sclerosis Complex.
@en
Combined Targeting of mTOR and ...... of Tuberous Sclerosis Complex.
@nl
P2093
P2860
P356
P1433
P1476
Combined Targeting of mTOR and ...... of Tuberous Sclerosis Complex.
@en
P2093
Fuquan Jin
Guanghe Fei
Xiaojun Zha
Zhaofei Ni
P2860
P304
P356
10.7150/JCA.17205
P577
2017-02-11T00:00:00Z